Literature DB >> 26045647

Pharmacological treatment of diabetic peripheral neuropathy.

Kenneth Cohen, Nataliya Shinkazh, Jerry Frank, Igor Israel, Chris Fellner.   

Abstract

Pain modulation is a key treatment goal for diabetic peripheral neuropathy patients. Guidelines have recommended antidepressant, anticonvulsant, analgesic, and topical medications-both approved and off-label-to reduce pain in this population.

Entities:  

Year:  2015        PMID： 26045647      PMCID： PMC4450668     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  141 in total

Review 1.  Opioid tolerance and hyperalgesia.

Authors:  Grace Chang; Lucy Chen; Jianren Mao
Journal:  Med Clin North Am       Date:  2007-03       Impact factor: 5.456

2.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

3.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

4.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

5.  Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.

Authors:  Ahmet Ulugol; Hakan C Karadag; Melek Tamer; Zeki Firat; Aysegul Aslantas; Ismet Dokmeci
Journal:  Neurosci Lett       Date:  2002-08-09       Impact factor: 3.046

6.  Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy.

Authors:  Phillip A Low; Tonette L Opfer-Gehrking; Peter J Dyck; William J Litchy; Peter C O'Brien
Journal:  Pain       Date:  1995-08       Impact factor: 6.961

7.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

Review 8.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

9.  Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.

Authors:  J A Rull; R Quibrera; H González-Millán; O Lozano Castañeda
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

Review 10.  Carbamazepine for chronic neuropathic pain and fibromyalgia in adults.

Authors:  Philip J Wiffen; Sheena Derry; R Andrew Moore; Eija A Kalso
Journal:  Cochrane Database Syst Rev       Date:  2014-04-10
View more
  13 in total

Review 1.  Diabetic Polyneuropathy - Advances in Diagnosis and Intervention Strategies.

Authors:  Solomon Tesfaye; Gordon Sloan
Journal:  Eur Endocrinol       Date:  2020-04-17

2.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 3.  Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.

Authors:  De-Qi Jiang; Lan-Cheng Xu; Li-Lin Jiang; Ming-Xing Li; Yong Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  Effectiveness of acupuncture for treatment of diabetic peripheral neuropathy.

Authors:  You-Jie Zhang; Fan-Rong Liu
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial.

Authors:  Yeek Tat Ng; Sonia Chew Wen Phang; Gerald Chen Jie Tan; En Yng Ng; Nevein Philip Botross Henien; Uma Devi M Palanisamy; Badariah Ahmad; Khalid Abdul Kadir
Journal:  Nutrients       Date:  2020-05-23       Impact factor: 5.717

Review 6.  Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review.

Authors:  Valeriu Ardeleanu; Alexandra Toma; Kalliopi Pafili; Nikolaos Papanas; Ion Motofei; Camelia Cristina Diaconu; Manfredi Rizzo; Anca Pantea Stoian
Journal:  Medicina (Kaunas)       Date:  2020-01-09       Impact factor: 2.430

7.  Anti-Cholinergic Drug Burden Among Ambulatory Elderly Patients in a Nigerian Tertiary Healthcare Facility.

Authors:  Joseph O Fadare; Abimbola Margaret Obimakinde; Felix O Aina; Ebisola J Araromi; Theophilus Adekunle Adegbuyi; Oluwatoba E Osasona; Tosin A Agbesanwa
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

8.  Acupuncture in diabetic peripheral neuropathy-protocol for the randomized, multicenter ACUDPN trial.

Authors:  J Dietzel; S Hörder; I V Habermann; G Meyer-Hamme; K Hahn; M Ortiz; S Roll; K Linde; D Irnich; M Hammes; R Nögel; M Wullinger; V Wortman; J Hummelsberger; S N Willich; S Schröder; B Brinkhaus
Journal:  Trials       Date:  2021-02-26       Impact factor: 2.279

9.  Effectiveness of acupuncture combined mecobalamin in the treatment of elderly diabetic peripheral neuropathy: A protocol of systematic review and meta-analysis.

Authors:  Yu-Hong Duan; Ai-Xia Liu; Hong-Xia Su; Ji-Hong Lv; Xue-Ying Gong; Li Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

10.  The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial.

Authors:  Razieh Avan; Ghasem Janbabaei; Narjes Hendouei; Abbas Alipour; Samaneh Borhani; Nasim Tabrizi; Ebrahim Salehifar
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.